Dong-Ming Kuang

sun yat-sen university

H指数:36

被引数:5,814

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumour-associated high endothelial venules drive portal-specific immune evasion in lymph nodes via ALOX12

肿瘤相关高内皮静脉通过ALOX12驱动淋巴结门特异性免疫逃逸

Nature Communications

IF15.7

2026-05-110

OAAI

THY1+ cancer stem cells drive metastasis through a pseudohypoxic state shaped by neutrophil-derived mitochondria

THY1癌症干细胞通过中性粒细胞衍生的线粒体形成的假缺氧状态驱动转移

Nature Cell Biology

IF19.1

2026-02-120

PRE

BCAT1-elicited branched-chain amino acid catabolism fosters neutrophil-mediated pan-metastasis in pancreatic ductal adenocarcinoma

Molecular Therapy

IF12

2026-02-020

PRE

Sensing of DNA double-strand breaks by the NHEJ system stabilizes RORγt transcriptional activity and shapes Th17 pathogenicity in autoimmunity

NHEJ系统对DNA双链断裂的感应可稳定ror γ t转录活性并在自身免疫中塑造Th17致病性

Cell Research

IF25.9

2026-01-070

OAAI

Glycolytic diversity drives immune complexity in cancer

糖酵解多样性驱动癌症中的免疫复杂性

Trends in Immunology

IF13.9

2025-12-020

PRE

Liver-breast communication of adipocyte-oriented exosomes drives primary mammary cancer progression

脂肪细胞来源的细胞外囊泡介导的肝脏-乳腺通讯驱动原发性乳腺癌症进展

Cell Metabolism

IF30.9

2025-09-240

PRE

Glucose restriction shapes pre-metastatic innate immune landscapes in the lung through exosomal TRAIL

葡萄糖限制通过外泌体TRAIL塑造肺内前转移性先天免疫景观

Cell

IF42.5

2025-07-150

PRE

Efflux of N1-acetylspermidine from hepatoma fosters macrophage-mediated immune suppression to dampen immunotherapeutic efficacy

N1-乙酰精脒从肝癌细胞中排出，促进了巨噬细胞介导的免疫抑制，从而削弱免疫治疗的效果。

Immunity

IF26.3

2025-06-020

PRE

Tribbles Pseudokinase 3 Converts Sorafenib Therapy to Neutrophil-Mediated Lung Metastasis in Hepatocellular Carcinoma

Tribbles Pseudokinase 3 将索拉非尼疗法转化为中性粒细胞介导的肝癌肺转移

ADVANCED SCIENCE

IF14.1

2025-02-110

OAAI

Pericancerous cross-presentation to cytotoxic T lymphocytes impairs immunotherapeutic efficacy in hepatocellular carcinoma

癌周交叉呈递对细胞毒性T淋巴细胞抑制了肝癌的免疫治疗效果

CANCER CELL

IF44.5

2024-12-012

PRE

Tertiary Lymphoid Structure-Associated B Cells Enhance Response to Programmed Cell Death Protein 1 Blockade in Cancer Immunotherapy

三级淋巴结构相关b细胞在癌症免疫治疗中增强对程序性细胞死亡蛋白1阻断的反应

GASTROENTEROLOGY

IF25.1

2024-06-018

miRNome targeting NF-κB signaling orchestrates macrophage-triggered cancer metastasis and recurrence

MOLECULAR THERAPY

IF12

2024-04-012

PRE

NK-cell-elicited gasdermin-D-dependent hepatocyte pyroptosis induces neutrophil extracellular traps that facilitates HBV-related acute-on-chronic liver failure

HEPATOLOGY

IF15.8

2024-03-275

PRE

Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer

EHMT2抑制诱导的Galectin-7增强微卫星稳定性大肠癌的免疫力

GASTROENTEROLOGY

IF25.1

2024-03-014

PRE

Targeting Ferroptosis-Elicited Inflammation Suppresses Hepatocellular Carcinoma Metastasis and Enhances Sorafenib Efficacy

CANCER RESEARCH

IF16.6

2024-01-1710

PRE

Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer

CANCER RESEARCH

IF16.6

2023-06-2318

PRE

The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment

NATURE MEDICINE

IF50

2023-06-0634

PRE

Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma

IMMUNITY

IF26.3

2023-01-0120

OAAI

Targeting inflammatory macrophages rebuilds therapeutic efficacy of DOT1L inhibition in hepatocellular carcinoma

MOLECULAR THERAPY

IF12

2023-01-013

OAAI

Regulation of autoimmune disease progression by Pik3ip1 through metabolic reprogramming in T cells and therapeutic implications

SCIENCE ADVANCES

IF12.5

2022-09-308

OAAI

Dong-Ming Kuang

个人简介

教育背景

工作经历

荣誉奖项

研究方向